title: Mechanisms of carbacholine and GABA action on resting membrane potential and Na+/K+-ATPase of Lumbricus terrestris body wall muscles.
abstract: This work was aimed to identify the action of several ion channel and pump inhibitors as well as nicotinic, GABAergic, purinergic and serotoninergic drugs on the resting membrane potential (RMP) and assess the role of cholinergic and GABAergic sensitivity in earthworm muscle electrogenesis. The nicotinic agonists acetylcholine (ACh), carbacholine (CCh) and nicotine depolarize the RMP at concentrations of 5 μM and higher. The nicotinic antagonists (+)tubocurarine, α-bungarotoxin, muscarinic antagonists atropine and hexamethonium do not remove or prevent the CCh-induced depolarization. Verapamil, tetrodotoxin, removal of Cl(-) and Ca(2+) from the solution also cannot prevent the depolarization by CCh. In a Na(+)-free medium, however, CCh lost this depolarization ability and this indicates that the drug opens the sodium permeable pathway. Serotonin, glutamate, glycine, adenosine triphosphate (ATP) and cis-4-aminocrotonic acid (GABA(C) receptor antagonist) had no effect on the RMP. On the other hand, isoguvacin, γ-aminobutyric acid (GABA) and baclofen (GABA(B) receptor agonist) hyperpolarized the RMP. Ouabain, bicucullin (GABA(A) antagonist) and phaclofen (GABA(B) antagonist), as well as the removal of Cl(-), suppressed the effect of GABA and baclofen. CCh did not enhance the depolarization generated by ouabain but, on the other hand, hindered the hyperpolarizing activity of baclofen both in the absence and presence of atropine and (+)tubocurarine. The long-term application of CCh depolarizes the RMP primarily by inhibiting the Na(+)/K(+)-ATPase. The muscle membrane also contains A and B type GABA binding sites, the activation of which increases the RMP at the expense of increasing the action of ouabain- and Cl(-) -sensitive electrogenic pumps.
authors.affiliation: State Medical University, Kazan, Russia.
authors.forename: Eugeny M
authors.initials: EM
authors.lastname: Volkov
authors.forename: Leniz F
authors.initials: LF
authors.lastname: Nurullin
authors.forename: Michael E
authors.initials: ME
authors.lastname: Volkov
authors.forename: Eugeny E
authors.initials: EE
authors.lastname: Nikolsky
authors.forename: Frantisek
authors.initials: F
authors.lastname: Vyskočil
mesh_terms: D000109:Acetylcholine / Q000494:pharmacology; D000255:Adenosine Triphosphate / Q000494:pharmacology; D000818:Animals; D002217:Carbachol / Q000494:pharmacology*; D018755:GABA Agonists / Q000494:pharmacology*; D018756:GABA Antagonists / Q000494:pharmacology; D018698:Glutamic Acid / Q000494:pharmacology; D005998:Glycine / Q000494:pharmacology; D007473:Ion Channels / Q000037:antagonists & inhibitors; D016623:Ion Pumps / Q000037:antagonists & inhibitors; D008564:Membrane Potentials / Q000187:drug effects*; D009132:Muscles / Q000187:drug effects / Q000201:enzymology / Q000502:physiology; D018722:Nicotinic Agonists / Q000494:pharmacology*; D009835:Oligochaeta / Q000187:drug effects / Q000201:enzymology / Q000502:physiology; D012701:Serotonin / Q000494:pharmacology; D000254:Sodium-Potassium-Exchanging ATPase / Q000037:antagonists & inhibitors*; D005680:gamma-Aminobutyric Acid / Q000494:pharmacology
chemical_list: D018755:GABA Agonists; D018756:GABA Antagonists; D007473:Ion Channels; D016623:Ion Pumps; D018722:Nicotinic Agonists; D012701:Serotonin; D018698:Glutamic Acid; D005680:gamma-Aminobutyric Acid; D000255:Adenosine Triphosphate; D002217:Carbachol; D000254:Sodium-Potassium-Exchanging ATPase; D000109:Acetylcholine; D005998:Glycine